Field of Research:
Pathology research aims to clarify the underlying
pathogenesis and etiology of various endemic diseases prevalent in our country
mainly affecting different body systems and organs (as GIT, liver,
genito-urinary system). The strategy thus contributes in clarifying
pathogenesis and establishing diagnosis of diseases as well as offering follow
up for prognosis and guiding treatment and therapeutic strategies in many
diseased cases. The pathological evaluation is the end station upon which
therapy is dependant and planned. The strategy aims also at:
1- Prediction of early neoplasia as
well as exploring chromosomal and gene aberrations associated with different
diseases using specific molecular pathology techniques.
2- Establishing a standardized
pathological evaluation for future organ transplantation including kidney and
liver transplantation.
3- Stem cell research: Establishing
standardized tissue evaluation for proper tracing of the different transplanted
types of stem cells (autologus bone marrow, umbilical cord blood) into their
targeted diseased organs and to find out their differentiation in both tissue
cultures and transplanted organs.
Main Achievements:
1-
The pathogenic characteristics of hepatic schistosomiasis from early acute to
chronic stages that got complicated by hepatic fibrosis were studied with the
following achievements:
(1)
Defining and immunolocalization of different hepatic collagens and (non
collagenous glycoproteins with the conclusion that the reversible collagen type
III is the first collagen type deposited in early granulomatous lesion followed
by the other irreversible types.
(2)
Detecting the distribution of different immuno-globulins within schistosomal
granuloma.
(3)
Semiquantitation of hepatic collagenous content which helped in judging
efficacy of tested antifibrotic drugs.
2- Pathological
evaluation of the efficacy as well as the toxic and side effects of many chemotherapeutic
drugs
a-
Antischistosomal drugs
b-
Anti-inflammatory and antifibrotic chemotherapeutic agents
c-
Anti-oxidants
3- Detection
of hidden schistosomal infection on tissue sections.
4-Experimental studies on vaccination
against Shistosoma mansoni infection
5-Experimental studies on hepatic
regeneration following partial hepatectomy, ischemic reperfusion injury, extra
hepatic vascular occlusion (hepatic artery or portal vein occlusion), or
toxaemia in bilharzial and non bilharzial liver to assess efficient procedure
to enhance hepatic regeneration after partial hepatectomy for focal hepatic
lesions.
6-
Pathology research topics on chronic viral hepatitis focus on clarifying the
etiological factors, scoring of necro-inflammatory activity and stages of
fibrosis, localization of different tissue markers involved in its
pathogenesis, and prediction of progress into cirrhosis or its complication to
precancerous or hepatocellular carcinoma with the following achievements:-
- Detection of HCV RNA and HBV DNA in hepatic tissue by in-situ
hybridization technique, with sensitivity of 52.6% and 27.3%, and
specificity of 97.5% and 96.6% for HCV and HBV affection.
- Immunohistochemical localization of tissue markers as:
1)
Inflammation associated markers as CD3, CD20, myeloperoxidase, ICAM,
COX-2, iNOS, CK18. It was found that their increased tissue expression
correlated with grade of disease activity and stage of fibrosis.
2)
Apoptotic markers
3)
Antiapoptotic markers as Bcl2.
4)
Natural killer cell markers
5)
Hepatic stellate cell activation markers
6)
Growth factors as transforming growth factor beta 1, basic fibroblast
growth factor.
7)
Angiogenic markers
8)
Proliferation markers
9)
Mitogenic markers
10)
Oncogenic markers
11)
Histone mRNA by in-situ hybridization with the conclusion that its
altered hepatic expression may be useful for early prediction of tumorgenic
changes.
7-
DNA assessment and morphometrical measurements of hepatocytes in
different hepatic lesions for early detection of dysplasia and neoplasia using
Image Analysis System.
8-
Experimental studies on stem cell culture and implantation.
9-Urinary schistosomal pathogenesis and its
possible consequence malignancy development:
(1) Immunohistochemical localization of
tissue markers .
(2) Study of ABH and lewis blood group
antigens modulated expression in saliva, sera, and bladder tissue in patients
with schistosomal associated cancer bladder.
(3) DNA assessment and morphometrical
measurements of bladder urothelium in schistosomal bladder lesions for early
detection of dysplasia and neoplasia using Image Analysis System.
(4) Detecting role of human papilloma
viruses (HPV types 6/11, 16/18, and 52) in schistosomal bladder carcinogenesis
by in situ Hypridization (ISH) techniques.
(5) Detection of shedded aneuploid urothelial cells
(have abnormal DNA content) in urine samples using Image Analysis System to be
applied being non invasive easily applicable valuable procedure for early
diagnosis of neoplasia.
No comments:
Post a Comment